|
30 Jul 2025 |
Piramal Enterprises
|
Consensus Share Price Target
|
1287.60 |
1043.57 |
- |
-18.95 |
sell
|
|
|
|
|
23 Jun 2025
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1250.00
|
1121.30
(14.83%)
|
Target met |
Neutral
|
|
|
We interacted with the senior management team of Piramal Enterprises (PIEL), represented by Mr. Jairam Sridharan, CEO of Retail Lending and MD of Piramal Finance, to gain insights into the company's future growth plans and other strategic developments.
|
|
06 May 2025
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1085.00
|
962.80
(33.73%)
|
Target met |
Neutral
|
|
|
Piramal Enterprises (PIEL) reported a 4QFY25 net profit of ~INR1b (PQ: ~INR386m). This included an exceptional gain of ~INR3.7b from recoveries in the AIF portfolio. For FY25, the total gain from the AIF portfolio stood at INR9.2b. FY25 net profit stood at INR4.85b (vs. a loss of INR16.8b in FY24).
|
|
27 Jan 2025
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1025.00
|
914.50
(40.80%)
|
Target met |
Neutral
|
|
|
Piramal Enterprises (PIEL) reported 3QFY25 net profit of ~INR386m (PQ: ~INR1.6b). This included exceptional gain of ~INR3.8b (PQ: INR770m) from recoveries in AIF portfolio.
|
|
23 Oct 2024
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1015.00
|
1044.25
(23.30%)
|
Target met |
Neutral
|
|
|
Piramal Enterprises (PIEL) reported a 2QFY25 net profit of ~INR1.6b (PQ: ~INR1.8b). This included an exceptional gain of ~INR770m from recoveries in the AIF portfolio.
|
|
11 Sep 2024
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1000.00
|
1043.35
(23.41%)
|
Target met |
Neutral
|
|
|
PIEL is committed to reducing its legacy AUM from ~INR130b as of Jun’24 to ~INR60-70b by Mar’25 and expects (not guidance) that a ~25% haircut.
|
|
14 Aug 2024
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
950.00
|
882.40
(45.92%)
|
Target met |
Neutral
|
|
|
PIEL reported 1QFY25 net profit of ~INR1.8b (PQ: ~INR1.4b). This included an exceptional gain of ~INR1b from recoveries in AIF portfolio.
|
|
30 Jan 2024
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1100.00
|
894.20
(43.99%)
|
Target met |
Buy
|
|
|
|
|
10 Nov 2023
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1200.00
|
945.75
(36.15%)
|
|
Buy
|
|
|
|
|
30 Jul 2023
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1260.00
|
1072.95
(20.01%)
|
|
Buy
|
|
|
|
|
02 Jul 2023
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1165.00
|
942.30
(36.64%)
|
|
Buy
|
|
|
|
|
07 May 2023
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1000.00
|
734.85
(75.22%)
|
Target met |
Buy
|
|
|
|
|
10 Feb 2023
|
Piramal Enterprises
|
ICICI Securities Limited
|
1287.60
|
1095.00
|
891.00
(44.51%)
|
Target met |
Buy
|
|
|
Piramal Enterprises (PEL) reported its first-ever positive quarterly PAT as an NBFC – at Rs35.5bn, well above our estimates. This was its second quarterly result as an NBFC post the demerger of Piramal Pharma. PAT was led by one-offs in terms of: i) income tax provision reversal of Rs33.3bn.
|
|
09 Feb 2023
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1150.00
|
837.10
(53.82%)
|
|
Buy
|
|
|
|
|
10 Nov 2022
|
Piramal Enterprises
|
ICICI Securities Limited
|
1287.60
|
1178.00
|
811.60
(58.65%)
|
|
Buy
|
|
|
Piramal Enterprises (PEL) once again disappointed, reporting a loss of Rs15bn in Q2FY23, as it provided Rs33bn (>5% of AUM) primarily towards wholesale portfolio.
|
|
10 Nov 2022
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1160.00
|
811.60
(58.65%)
|
|
Buy
|
|
|
|
|
15 Sep 2022
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
1320.00
|
964.55
(33.49%)
|
|
Buy
|
|
|
|
|
01 Sep 2022
|
Piramal Enterprises
|
ICICI Securities Limited
|
1287.60
|
1391.00
|
1063.55
(21.07%)
|
|
Buy
|
|
|
Piramal Enterprises (PEL) has fixed September 1, ‘22 as demerger of Piramal Pharma record date.
|
|
31 Jul 2022
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
2200.00
|
1749.90
(-26.42%)
|
|
Buy
|
|
|
|
|
27 May 2022
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
2250.00
|
1645.30
(-21.74%)
|
|
Buy
|
|
|
|
|
11 Feb 2022
|
Piramal Enterprises
|
Motilal Oswal
|
1287.60
|
3200.00
|
2422.40
(-46.85%)
|
|
Buy
|
|
|
Piramal Enterprises (PIEL) reported a healthy 3QFY22 result, characterized by various factors. a) 44% QoQ growth in retail disbursements exhibited momentum and will continue to improve hereon b) GNPA/NNPA increased just 40bp/30bp QoQ to 3.3%/1.8%, driven by one slippage in the Wholesale segment and the impact of the RBI NPA circular and yet PIEL delivered net provision write-backs. c) The focus was on execution, resulting in steady progress on the articulated strategy and the DHFL integration. d) Ten live fintech and consumer-tech partnerships are evolving well and contributed 96%...
|